{"id":1321,"date":"2016-08-10T14:21:33","date_gmt":"2016-08-10T05:21:33","guid":{"rendered":"http:\/\/www.tsukuba-psychiatry.com\/?page_id=1321"},"modified":"2020-09-16T14:44:40","modified_gmt":"2020-09-16T05:44:40","slug":"2014%e5%b9%b4%e5%ba%a6%e6%a5%ad%e7%b8%be","status":"publish","type":"page","link":"https:\/\/www.tsukuba-psychiatry.com\/?page_id=1321","title":{"rendered":"2014\u5e74\u5ea6\u696d\u7e3e"},"content":{"rendered":"

\u79c1\u305f\u3061\u7cbe\u795e\u533b\u5b66\u30b0\u30eb\u30fc\u30d7\u306e2014\u5e74\u306e\u696d\u7e3e\u3092\u7d39\u4ecb\u3057\u307e\u3059\u3002<\/p>\n

\u539f\u8457<\/p>\n

    \n
  1. Yoshita M, Arai H, Arai H, Arai T<\/u>, Asada T, Fujishiro H, Hanyu H, Iizuka O, Iseki E, Kashihara K, Kosaka K, Maruno H, Mizukami K, Mizuno Y, Mori E, Nakajima K, Nakamura H, Nakano S, Nakashima K, Nishio Y, Orimo S, Samuraki M, Takahashi A, Taki J, Tokuda T, Urakami K, Utsumi K, Wada K, Washimi Y, Yamashina S, Yamazaki J, Yamada M: Diagnostic accuracy of cardiac sympathetic imaging with 123I-MIBG myocardial scintigraphy in dementia with Lewy bodies: a multicenter study. PLoS One 10: e0120540, 2015.3.20.<\/li>\n
  2. Hosokawa M, Arai T<\/u>, Masuda-Suzukake M, Kondo H, Matsuwaki T, Nishihara M, Hasegawa M, Akiyama H: Progranulin reduction is associated with increased tau phosphorylation in P301L tau transgenic mice. J Neuropathol Exp Neurol 74: 158-165, 2015.2<\/li>\n
  3. Arai T. Significance and limitation of the pathological classification of TDP-43 proteinopathy. Neuropathology 34(6):578-588, 2014<\/li>\n
  4. Inagaki M, Kawashima Y, Kawanishi C, Yonemoto N, Sugimoto T, Furuno T, Ikeshita K, Eto N, Tachikawa H, Shiraishi Y, Yamada M. Interventions to prevent repeat suicidal behavior in patients admitted to an emergency department for a suicide attempt: a meta-analysis. J Affect Disord doi: 10.1016\/j.jad.2014.12.048, 2014<\/li>\n
  5. Hashimoto R, Ikeda M, Yamashita F, Ohi K, Yamamori H, Yasuda Y, Fujimoto M, Fukunaga M, Nemoto K, Takahashi T, Tochigi M, Onitsuka T, Yamasue H, Matsuo K, Iidaka T, Iwata N, Suzuki M, Takeda M, Kasai K, Ozaki N. Common variants at 1p36 are associated with superior frontal gyrus volume. Transl Psychiatry 4:e472, 2014<\/li>\n
  6. Yamashita M, Nonaka T, Hirai S, Miwa A, Okado H, Arai T<\/u>, Hosokawa M, Akiyama H, Hasegawa M: Distinct pathways leading to TDP-43-induced cellular dysfunctions. Hum Mol Genet 23: 4345-4356, 2014.<\/li>\n
  7. Kido M, Nakamura Y, Nemoto K, Takahashi T, Aleksic B, Furuichi A, Nakamura Y, Ikeda M, Noguchi K, Kaibuchi K, Iwata N, Ozaki N, Suzuki M. The polymorphism of YWHAE, a gene encoding 14-3-3epsilon, and brain morphology in schizophrenia: a voxel-based morphometric study. PLoS One 9(8):e103571, 2014<\/li>\n
  8. Ota M, Ishikawa M<\/u>, Sato N, Okazaki M, Maikusa N, Hori H, Hattori K, Teraishi T, Ito K, Kunugi H. Pseudo-continuous arterial spin labeling MRI study of schizophrenic patients. Schizophr Res 154(1-3):113-118, 2014<\/li>\n
  9. Tagai K, Nagata T, Shinagawa S, Nemoto K<\/u>, Inamura K, Tsuno N, Nakayama K. Correlation between both morphologic and functional changes and anxiety in Alzheimer’s disease. Dement Geriatr Cogn Disord 38(3-4):153-160, 2014<\/li>\n
  10. Ohi K, Hashimoto R, Ikeda M, Yamashita F, Fukunaga M, Nemoto K, Ohnishi T, Yamamori H, Yasuda Y, Fujimoto M, Umeda-Yano S, Watanabe Y, Iwata N, Weinberger DR, Takeda M. Genetic risk variants of schizophrenia associated with left superior temporal gyrus volume. Cortex 58:23-26, 2014<\/li>\n
  11. Hosokawa M, Arai T<\/u>, Yamashita M, Tsuji H, Nonaka T, Masuda-Suzukake M, Tamaoka A, Hasegawa M, Akiyama H: Differential diagnosis of amyotrophic lateral sclerosis from Guillain\u2013Barre\u00b4 syndrome by quantitative determination of TDP-43 in cerebrospinal fluid. Int J Neurosci 124: 344-349, 2014.5<\/li>\n
  12. Kawakami I, Hasegawa M, Arai T, Ikeda K, Oshima K, Niizato K, Aoki N, Omi K, Higashi S, Hosokawa M, Hirayasu Y, Akiyama H: Tau accumulation in the nucleus accumbens in tangle-predominant dementia. Acta Neuropathol Commun. 2: 40, 2014.<\/li>\n
  13. Shiratori Y, Tachikawa H, Nemoto K, Endo G, Aiba M, Matsui Y, Asada T. Network analysis for motives in suicide cases: a cross-sectional study. Psychiatry Clin Neurosci 68(4):299-307, 2014<\/li>\n
  14. \u5fd7\u8cc0\u5f18\u5e78, \u6839\u672c\u6e05\u8cb4, \u9ad8\u6a4b\u6676, \u65b0\u4e95\u54f2\u660e, \u671d\u7530\u9686. \u7dad\u6301\u4fee\u6b63\u578b\u96fb\u6c17\u3051\u3044\u308c\u3093\u7642\u6cd5\u306e\u6709\u7528\u6027\u3000\u5e74\u9593\u5165\u9662\u65e5\u6570\u306e\u691c\u8a0e\u304b\u3089. \u7cbe\u795e\u79d1\u6cbb\u7642\u5b66 29(1):127-132, 2014<\/li>\n
  15. \u7530\u53e3\u9ad8\u4e5f, \u6839\u672c\u6e05\u8cb4, \u592a\u5200\u5ddd\u5f18\u548c, \u9577\u91ce\u5fb9, \u7acb\u82b1\u9686\u8f1d, \u897f\u6751\u96c5\u53f2, \u65b0\u4e95\u54f2\u660e, \u671d\u7530\u9686. \u7814\u7a76\u3068\u5831\u544a OpenEAR\u3092\u7528\u3044\u305f\u97f3\u58f0\u306b\u3088\u308b\u5fc3\u7406\u7684\u30b9\u30c8\u30ec\u30b9\u691c\u51fa\u306e\u8a66\u307f. \u7cbe\u795e\u533b\u5b66 56(12):1027-1034, 2014<\/li>\n<\/ol>\n

     <\/p>\n

    \u7dcf\u8aac<\/p>\n

      \n
    1. \u65b0\u4e95\u54f2\u660e\uff1a TDP-43\u86cb\u767d\u75c7. \u795e\u7d4c\u75c5\u7406\u8a3a\u65ad\u306e\u6a19\u6e96\u5316I. \u75c5\u7406\u3068\u81e8\u5e8a, 33: 283-288, 2015<\/li>\n
    2. \u592a\u5200\u5ddd\u5f18\u548c. \u81ea\u6bba\u4e88\u9632\u3068\u30e1\u30c7\u30a3\u30a2\u2212\u30a6\u30a7\u30eb\u30c6\u30eb\u52b9\u679c\u3068\u30d1\u30d1\u30b2\u30fc\u30ce\u52b9\u679c\u2212. \u7cbe\u795e\u79d1\u6cbb\u7642\u5b66 30(3): 73-78<\/li>\n
    3. \u6839\u672c\u6e05\u8cb4, \u7530\u6751\u660c\u58eb, \u65b0\u4e95\u54f2\u660e, \u671d\u7530\u9686\uff1a\u5065\u5e38\u5f8c\u671f\u9ad8\u9f62\u8005\u306eTc-99m\u00a0ECD\u8133\u8840\u6d41SPECT\u30c7\u30fc\u30bf\u30d9\u30fc\u30b9\u306e\u958b\u767a. Pharma Medica 32: 62-63, 2014<\/li>\n
    4. Arai T: Significance and limitation of the pathological classification of TDP-43 proteinopathy. Neuropathology 34: 578-588, 2014<\/li>\n
    5. \u65b0\u4e95\u54f2\u660e:BPSD\u5bfe\u5fdc\u306e\u73fe\u72b6\u3068\u5c55\u671b. BIO Clinica 29: 42-46, 2014<\/li>\n
    6. \u77f3\u5ddd\u6b63\u61b2, \u592a\u5200\u5ddd\u5f18\u548c, \u77f3\u4e95\u6620\u7f8e, \u5800\u5b5d\u6587, \u671d\u7530\u9686. \u3010\u5927\u5b66\u751f\u3068\u30e1\u30f3\u30bf\u30eb\u30d8\u30eb\u30b9-\u4fdd\u5065\u7ba1\u7406\u30bb\u30f3\u30bf\u30fc\u306e\u30c1\u30e3\u30ec\u30f3\u30b8\u3011 \u7b51\u6ce2\u5927\u5b66\u4fdd\u5065\u7ba1\u7406\u30bb\u30f3\u30bf\u30fc\u306b\u304a\u3051\u308b\u7559\u5e74,\u4f11\u5b66\u5bfe\u7b56\u3000\u5b66\u751f\u30ea\u30b9\u30bf\u30fc\u30c8\u30d7\u30ed\u30b8\u30a7\u30af\u30c8\u306b\u3064\u3044\u3066. \u7cbe\u795e\u533b\u5b66 56(5):423-428, 2014<\/li>\n
    7. \u592a\u5200\u5ddd\u5f18\u548c. \u300c\u81ea\u6bba\u4f01\u56f3\u306e\u518d\u767a\u9632\u6b62\u306b\u95a2\u3059\u308b\u8907\u5408\u7684\u30b1\u30fc\u30b9\u30fb\u30de\u30cd\u30b8\u30e1\u30f3\u30c8\u306e\u52b9\u679c\uff1a\u591a\u65bd\u8a2d\u5171\u540c\u306b\u3088\u308b\u7121\u4f5c\u70ba\u5316\u6bd4\u8f03\u7814\u7a76\uff08ACTION-J\uff09\u300d\u306e\u5c55\u958b. \u7cbe\u795e\u79d1 25(1):34-38, 2014<\/li>\n
    8. \u6839\u672c\u6e05\u8cb4, \u7530\u6751\u660c\u58eb, \u65b0\u4e95\u54f2\u660e, \u671d\u7530\u9686. \u5065\u5e38\u5f8c\u671f\u9ad8\u9f62\u8005\u306eTc-99m ECD\u8133\u8840\u6d41SPECT\u30c7\u30fc\u30bf\u30d9\u30fc\u30b9\u306e\u958b\u767a. Pharma Medica 32(11):62-63, 2014<\/li>\n
    9. \u5800\u5b5d\u6587, \u592a\u5200\u5ddd\u5f18\u548c, \u77f3\u4e95\u6620\u7f8e. \u6559\u80b2\u73fe\u5834\u306b\u304a\u3051\u308b\u5065\u5eb7\u7ba1\u7406\u3000\u7b51\u6ce2\u5927\u5b66\u306b\u304a\u3051\u308b\u30e1\u30f3\u30bf\u30eb\u30d8\u30eb\u30b9\u3078\u306e\u30a2\u30d7\u30ed\u30fc\u30c1. \u81e8\u5e8a\u691c\u67fb\u5b66\u6559\u80b2 6(2):107-111, 2014<\/li>\n
    10. \u677e\u5d0e\u671d\u6a39. DSM-5\u3092\u901a\u3057\u3066\u898b\u305f\u300c\u3046\u3064\u75c5\u300d\u306e\u81e8\u5e8a. Depression Frontier 12(2):84-86, 2014<\/li>\n
    11. \u767d\u9ce5\u88d5\u8cb4, \u592a\u5200\u5ddd\u5f18\u548c. \u81ea\u6bba\u306e\u30ea\u30b9\u30af\u8a55\u4fa1\u306b\u304a\u3044\u3066\u4f55\u306b\u6ce8\u610f\u3059\u3079\u304d\u304b\u2212\u8b66\u5bdf\u5e81\u30c7\u30fc\u30bf\u3092\u7528\u3044\u305f\u30cd\u30c3\u30c8\u30ef\u30fc\u30af\u5206\u6790\u304b\u3089\u898b\u3048\u3066\u304d\u305f\u3053\u3068\u2212. \u7cbe\u795e\u79d1\u6cbb\u7642\u5b66 30(3):11-18<\/li>\n<\/ol>\n

       <\/p>\n

      \u8457\u66f8<\/p>\n

        \n
      1. \u65b0\u4e95\u54f2\u660e\uff1a\u5909\u6027\u6027\u8a8d\u77e5\u75c7\uff08\u30a2\u30eb\u30c4\u30cf\u30a4\u30de\u30fc\u75c5, \u30ec\u30d3\u30fc\u5c0f\u4f53\u578b\u8a8d\u77e5\u75c7\u3092\u9664\u304f\uff09. \u4eca\u65e5\u306e\u6cbb\u7642\u6307\u91dd (\u5c71\u53e3\u5fb9, \u5317\u539f\u5149\u592b\u76e3\u4fee). \u533b\u5b66\u66f8\u9662, 948-949, 2015<\/li>\n
      2. \u677e\u5d0e\u671d\u6a39: \u8a9e\u5442\u3067\u899a\u3048\u308b\uff01DSM-5. \u30e1\u30c7\u30a3\u30ab\u30eb\u30fb\u30b5\u30a4\u30a8\u30f3\u30b9\u30fb\u30a4\u30f3\u30bf\u30fc\u30ca\u30b7\u30e7\u30ca\u30eb, 2015<\/li>\n
      3. \u677e\u5d0e\u671d\u6a39:\u00a0DSM-5\u3092\u3064\u304b\u3046\u3068\u3044\u3046\u3053\u3068 \u305d\u306e\u53ef\u80fd\u6027\u3068\u9650\u754c, \u30e1\u30c7\u30a3\u30ab\u30eb\u30fb\u30b5\u30a4\u30a8\u30f3\u30b9\u30fb\u30a4\u30f3\u30bf\u30fc\u30ca\u30b7\u30e7\u30ca\u30eb, 2015<\/li>\n
      4. \u6839\u672c\u6e05\u8cb4\uff1a\u3059\u3050\u3067\u304d\u308bVBM. \u79c0\u6f64\u793e, \u00a02014\u5e74<\/li>\n
      5. \u677e\u5d0e\u671d\u6a39: \u300c\u5bb6\u65cf\u306e\u7dca\u6025\u4e8b\u614b\u306b\u306f\uff1f\u300d\u300c\u85ac\u3092\u62d2\u5426\u3059\u308b\u4eba\u306b\u306f\uff1f\u300d\u300c\u518d\u767a\u306e\u524d\u89e6\u308c\u30fb\u5146\u3057\u3068\u6c17\u3092\u4ed8\u3051\u308b\u30dd\u30a4\u30f3\u30c8\u300d; “\uff31\uff06\uff21\u3067\u308f\u304b\u308b\u3000\u3053\u3053\u308d\u306e\u75c5\u306e\u7591\u554f\uff11\uff10\uff10\u3000\u2015\u5f53\u4e8b\u8005\u30fb\u5bb6\u65cf\u30fb\u652f\u63f4\u8005\u306b\u5f79\u7acb\u3064\u77e5\u8b58 (\u7b2c1\u7248)\u201d (\u7de8\u96c6 \u9ad8\u6a4b\u6e05\u4e45, \u6709\u99ac\u90a6\u6b63), \u4e2d\u592e\u6cd5\u898f\u51fa\u7248 (\u6771\u4eac) 2014; pp114-119<\/li>\n<\/ol>\n

         <\/p>\n

        \u5b66\u4f1a\u767a\u8868<\/p>\n

          \n
        1. \u548c\u5bb6\u5c1a\u5e0c,\u00a0\u9234\u6728\u96c5\u4e4b,\u00a0\u9577\u91ce\u5fb9,\u00a0\u7acb\u82b1\u9686\u8f1d,\u00a0\u897f\u6751\u96c5\u53f2,\u00a0\u7530\u53e3\u9ad8\u4e5f,\u00a0\u6839\u672c\u6e05\u8cb4,\u00a0\u592a\u5200\u5ddd\u5f18\u548c:\u00a0\u7cbe\u795e\u75be\u60a3\u8a3a\u65ad\u88dc\u52a9\u306b\u6709\u52b9\u306a\u767a\u8a71\u8ab2\u984c\u3068\u97f3\u58f0\u7279\u5fb4\u306b\u95a2\u3059\u308b\u691c\u8a0e.\u00a02015\u5e741\u6708\u5ea6\u96fb\u5b50\u60c5\u5831\u901a\u4fe1\u5b66\u4f1a \u97f3\u58f0\u7814\u7a76\u4f1a\uff08\uff33\uff30\uff09, 2015\u5e7401\u670822\u65e5<\/li>\n
        2. \u65b0\u4e95\u54f2\u660e, \u5b89\u90e8\u79c0\u4e09, \u6817\u7530\u88d5\u6587, \u5927\u5ddd\u6075\u5b50, \u6c60\u5d8b\u5343\u79cb, \u592a\u5200\u5ddd\u5f18\u548c, \u6c60\u7530\u5b66, \u70cf\u5e3d\u5b50\u7530\u5f70, \u5317\u6751\u7acb, \u677e\u5ca1\u7167\u4e4b, \u5b89\u91ce\u53f2\u5f66, \u6a2a\u7530\u4fee, \u671d\u7530\u9686: \u5730\u57df\u578b\u8a8d\u77e5\u75c7\u75be\u60a3\u533b\u7642\u30bb\u30f3\u30bf\u30fc\u306b\u5165\u9662\u3057\u305f\u8a8d\u77e5\u75c7\u60a3\u8005\u306b\u8a8d\u3081\u3089\u308c\u308bBPSD\u306e\u5b9f\u614b. \u7b2c33\u56de\u65e5\u672c\u8a8d\u77e5\u75c7\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a, \u6a2a\u6d5c, 2014\u5e7412\u67081\u65e5<\/li>\n
        3. \u7d30\u5ddd\u96c5\u4eba, \u65b0\u4e95\u54f2\u660e, \u5897\u7530-\u9234\u639b\u96c5\u7f8e, \u8fd1\u85e4\u3072\u308d\u307f, \u677e\u8107\u8cb4\u5fd7, \u897f\u539f\u771f\u6749, \u9577\u8c37\u5ddd\u6210\u4eba, \u79cb\u5c71\u6cbb\u5f66: \u30d7\u30ed\u30b0\u30e9\u30cb\u30e5\u30ea\u30f3\u306e\u6e1b\u5c11\u306f\u30bf\u30a6\u306e\u30ea\u30f3\u9178\u5316\u3092\u4ea2\u9032\u3055\u305b\u308b. \u7b2c33\u56de\u65e5\u672c\u8a8d\u77e5\u75c7\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a, \u6a2a\u6d5c, 2014\u5e7411\u670830\u65e5<\/li>\n
        4. \u7530\u53e3\u3000\u9ad8\u4e5f, \u592a\u5200\u5ddd \u5f18\u548c, \u6839\u672c\u6e05\u8cb4, \u9234\u6728\u96c5\u4e4b, \u9577\u91ce\u3000\u5fb9…;\u00a0\u3046\u3064\u75c5\u306e\u8a3a\u65ad\u30fb\u75c7\u72b6\u8a55\u4fa1\u306b\u95a2\u3059\u308b\u97f3\u58f0\u30d0\u30a4\u30aa\u30de\u30fc\u30ab\u30fc\u306e\u691c\u8a0e,\u00a0\u7b2c34\u56de\u65e5\u672c\u7cbe\u795e\u79d1\u8a3a\u65ad\u5b66\u4f1a, 2014\u5e7411\u6708<\/li>\n
        5. \u95a2\u6839\u5f69, \u6839\u672c \u6e05\u8cb4, \u00a0\u795e\u5d07\u6176, \u65b0\u4e95\u54f2\u660e, \u671d\u7530\u9686;\u00a0\u6fc0\u8d8a\u3046\u3064\u75c5\u3068\u8a3a\u65ad\u3055\u308c\u3066\u3044\u305f\u55dc\u9280\u9846\u7c92\u6027\u8a8d\u77e5\u75c7\u3068\u30ec\u30d3\u30fc\u5c0f\u4f53\u578b\u8a8d\u77e5\u75c7\u306e\u5408\u4f75\u304c\u7591\u308f\u308c\u308b1\u4f8b,\u00a0\u7b2c36\u56de\u8328\u57ce\u533b\u5b66\u4f1a\u7cbe\u795e\u79d1\u5206\u79d1\u4f1a, 2014\u5e7411\u6708<\/li>\n
        6. \u6839\u672c \u6e05\u8cb4,\u00a0\u7cbe\u795e\u79d1\u533b\u306e\u89b3\u70b9\u304b\u3089\u306e\u8133MRI,\u8133\u8840\u6d41SPECT\u306e\u307f\u304b\u305f,\u00a0\u7b2c27\u56de\u65e5\u672c\u7dcf\u5408\u75c5\u9662\u7cbe\u795e\u533b\u5b66\u4f1a\u7dcf\u4f1a, 2014\u5e7411\u6708<\/li>\n
        7. Arai T, Kawakami I, Kobayashi Z, Yokota O, Niizato K, Oshima K, Hosokawa M, Akiyama H: Does frontotemporal dementia associated with chorea suggest the diagnosis of frontotemporal lobar degeneration with fused in sarcoma positive inclusions of the basophilic inclusion body disease subtype? 9th International Conference on frontotemporal dementias. Vancouver, Canada, October 23-25, 2014<\/li>\n
        8. \u7551\u4e2d\u516c\u5b5d, \u65b0\u4e95\u54f2\u660e, \u5ca9\u5207\u96c5\u5f66, \u4e95\u51fa\u653f\u884c, \u7530\u4e2d\u82b3\u90ce, \u671d\u7530\u9686: \u983b\u56de\u306e\u30d1\u30cb\u30c3\u30af\u767a\u4f5c\u304a\u3088\u3073\u4e0d\u5b89\u7126\u71e5\u611f\u304c\u6301\u7d9a\u3057\u305f\u975e\u5b9a\u578b\u7684\u8a8d\u77e5\u75c7\u306e\uff11\u5256\u691c\u4f8b. \u7b2c19\u56de\u65e5\u672c\u795e\u7d4c\u7cbe\u795e\u533b\u5b66\u4f1a, \u3064\u304f\u3070\u5e02, 2014\u5e7410\u67081\u65e5<\/li>\n
        9. \u95a2\u6839\u5f69, \u6839\u672c\u6e05\u8cb4, \u795e\u5d07\u6176, \u65b0\u4e95\u54f2\u660e, \u671d\u7530\u9686: \u6fc0\u8d8a\u3046\u3064\u75c5\u3068\u8a3a\u65ad\u3055\u308c\u3066\u3044\u305f\u3001\u55dc\u9280\u6027\u9846\u7c92\u8a8d\u77e5\u75c7\u3068Lewy\u5c0f\u4f53\u578b\u8a8d\u77e5\u75c7\u306e\u5408\u4f75\u304c\u7591\u308f\u308c\u305f\u4e00\u4f8b. \u7b2c19\u56de\u65e5\u672c\u795e\u7d4c\u7cbe\u795e\u533b\u5b66\u4f1a, \u3064\u304f\u3070\u5e02, 2014\u5e7410\u67081\u65e5<\/li>\n
        10. \u6839\u672c\u6e05\u8cb4, \u7530\u6751\u660c\u58eb, \u52a0\u85e4\u5b88\u5321, \u677e\u7530\u535a\u53f2, \u65b0\u4e95\u54f2\u660e, \u5f81\u77e2\u82f1\u662d, \u671d\u7530\u9686: \u8efd\u5ea6\u904b\u52d5\u306b\u3088\u308b\u9ad8\u9f62\u8005\u306e\u6954\u524d\u90e8\u304a\u3088\u3073\u524d\u982d\u524d\u91ce\u306b\u304a\u3051\u308b\u8133\u8840\u6d41. \u7b2c19\u56de\u65e5\u672c\u795e\u7d4c\u7cbe\u795e\u533b\u5b66\u4f1a, \u3064\u304f\u3070\u5e02, 2014\u5e7410\u67081\u65e5<\/li>\n
        11. \u6771\u664b\u4e8c, \u65b0\u4e95\u54f2\u660e, \u671d\u7530\u9686: TDP-43\u6b20\u640d\u5909\u7570\u4f53\u767a\u73fe\u304c\u4e0e\u3048\u308bPoly(A)+RNA\u5c40\u5728\u3078\u306e\u5f71\u97ff. \u7b2c19\u56de\u65e5\u672c\u795e\u7d4c\u7cbe\u795e\u533b\u5b66\u4f1a, \u3064\u304f\u3070\u5e02, 2014\u5e7410\u67081\u65e5<\/li>\n
        12. \u6839\u672c\u6e05\u8cb4, \u7530\u6751\u660c\u58eb, \u65b0\u4e95\u54f2\u660e, \u671d\u7530\u9686: 80\u6b73\u4ee5\u4e0a\u306e\u5065\u5e38\u5f8c\u671f\u9ad8\u9f62\u8005\u306eTc-99m ECD\u8133\u8840\u6d41SPECT\u30c7\u30fc\u30bf\u30d9\u30fc\u30b9\u306e\u958b\u767a. \u7b2c19\u56de\u65e5\u672c\u795e\u7d4c\u7cbe\u795e\u533b\u5b66\u4f1a, \u3064\u304f\u3070\u5e02, 2014\u5e7410\u67081\u65e5<\/li>\n
        13. Tachikawa, H., Okamoto, Y., Aiba, M., Shiga, H., Arai, T., & Asada, T;\u00a0Relationships between bullying and suicide described in newspaper: time series content analyses of news reports for the case of \u2018Ohtsu bullying-related suicide\u2019.15th European Society of Suicide and Suicidal Behavior\u00a0\u00a0\u00a0221 , 2014\u5e748\u6708<\/li>\n
        14. \u516a\u5584\u82f1, \u677e\u4e95\u8c4a, \u592a\u5200\u5ddd\u5f18\u548c, \u76f8\u7fbd\u7f8e\u5e78, \u9060\u85e4\u525b, \u798f\u5ca1\u6b23\u6cbb, \u571f\u4e95\u6c38\u53f2, \u671d\u7530\u9686;\u00a0\u4e00\u822c\u6210\u4eba\u306e\u5bb6\u65cf\u306b\u5bfe\u3059\u308b\u30b9\u30c8\u30ec\u30b9\u958b\u793a\u6291\u5236\u614b\u5ea6\u3068\u6291\u3046\u3064\u306e\u95a2\u9023,\u00a0\u65e5\u672c\u793e\u4f1a\u5fc3\u7406\u5b66\u4f1a\u7b2c55\u56de\u5927\u4f1a, 2014\u5e747\u670827\u65e5<\/li>\n
        15. \u76f8\u7fbd\u7f8e\u5e78, \u592a\u5200\u5ddd\u5f18\u548c, \u677e\u4e95\u8c4a, \u798f\u5ca1\u6b23\u6cbb;\u00a0\u81ea\u6bba\u5ff5\u616e\u3068\u81ea\u6bba\u306e\u5bfe\u4eba\u95a2\u4fc2\u7406\u8ad6,\u00a0\u65e5\u672c\u793e\u4f1a\u5fc3\u7406\u5b66\u4f1a\u7b2c55\u56de\u5927\u4f1a, 2014\u5e747\u6708<\/li>\n
        16. \u5ca1\u672c\u96c4\u592a, \u592a\u5200\u5ddd \u5f18\u548c, \u5fd7\u8cc0\u5f18\u5e78, \u671d\u7530\u3000\u9686;\u00a0\u65b0\u805e\u5831\u9053\u306b\u304a\u3051\u308b\u3044\u3058\u3081\u3068\u81ea\u6bba\u306e\u95a2\u4fc2\uff0d\u4e8b\u4ef6\u8a18\u4e8b\u306e\u6642\u7cfb\u5217\u5185\u5bb9\u5206\u6790\u2015,\u00a0\u7b2c11\u56de\u65e5\u672c\u3046\u3064\u75c5\u5b66\u4f1a\u7dcf\u4f1a, 2014\u5e747\u6708<\/li>\n
        17. Arai T, Abe S, Kurita H, Ikeda M, Eboshida A, Kitamura T, Matsuoka T, Yasuno F, Yokota O, Asada T: Clinical characteristics of demented patients with prolonged stay in a psychiatric hospital in Japan. Alzheimer\u2019s Association International Conference 2014, Copenhagen, Denmark, July 14, 2014<\/li>\n
        18. \u91ce\u5c3b \u7f8e\u6d41, \u592a\u5200\u5ddd \u5f18\u548c, \u9ad8\u5c3e \u54f2\u4e5f, \u5ddd\u897f \u6d0b\u4e00, \u8c37\u5411 \u77e5, \u00a0\u65b0\u4e95 \u54f2\u660e, \u00a0\u671d\u7530\u9686;\u00a0\u6c17\u5206\u969c\u5bb3\u95a2\u9023\u907a\u4f1d\u5b50\u591a\u578b\u306e\u7db2\u7f85\u7684\u89e3\u6790,\u00a0\u7b2c110\u56de\u65e5\u672c\u7cbe\u795e\u795e\u7d4c\u5b66\u4f1a\u5b66\u8853\u7dcf\u4f1a, 2014\u5e746\u6708<\/li>\n
        19. \u7530\u53e3 \u9ad8\u4e5f, \u592a\u5200\u5ddd \u5f18\u548c, \u6839\u672c \u6e05\u8cb4, \u9234\u6728 \u96c5\u4e4b, \u9577\u91ce \u5fb9, \u7acb\u82b1 \u9686\u8f1d, \u897f\u6751 \u96c5\u53f2, \u671d\u7530 \u9686;\u00a0\u97f3\u58f0\u3092\u7528\u3044\u305f\u65e5\u5e38\u751f\u6d3b\u306b\u304a\u3051\u308b\u30b9\u30c8\u30ec\u30b9\u8a55\u4fa1\u306e\u4e88\u5099\u7684\u691c\u8a0e,\u00a0\u7b2c110\u56de\u65e5\u672c\u7cbe\u795e\u795e\u7d4c\u5b66\u4f1a\u5b66\u8853\u7dcf\u4f1a, 2014\u5e746\u6708<\/li>\n
        20. \u539a\u6771\u77e5\u6210, \u65b0\u91cc\u548c\u5f18, \u65b0\u4e95\u54f2\u660e, \u9f4b\u85e4\u6b63\u5f66: \u77f3\u7070\u6c88\u7740\u3092\u4f34\u3046\u3073\u307e\u3093\u6027\u795e\u7d4c\u539f\u7dda\u7dad\u5909\u5316\u75c5 (DNTC)\u306e2\u4f8b. \u7b2c29\u56de\u65e5\u672c\u8001\u5e74\u7cbe\u795e\u533b\u5b66\u4f1a, \u6771\u4eac, 2014\u5e746\u670813\u65e5<\/li>\n
        21. \u6cb3\u4e0a\u7dd2, \u6c60\u7530\u7814\u4e8c, \u65b0\u4e95\u54f2\u660e, \u5927\u5cf6\u5065\u4e00, \u65b0\u91cc\u548c\u5f18, \u52dd\u702c\u5927\u6d77, \u5e73\u5b89\u826f\u96c4: tangle-predominant dementia\u306e\u7cbe\u795e\u533b\u5b66\u7684\u7279\u5fb4. \u7b2c29\u56de\u65e5\u672c\u8001\u5e74\u7cbe\u795e\u533b\u5b66\u4f1a, \u6771\u4eac, 2014\u5e746\u670813\u65e5<\/li>\n
        22. \u6d45\u898b\u5927\u7d00, \u7fbd\u7530\u821e\u5b50, \u65b0\u6cbc\u9928\u5353\u4e5f, \u77f3\u5ddd\u6b63\u61b2, \u65b0\u4e95\u54f2\u660e, \u671d\u7530\u9686: \u8efd\u5ea6\u8a8d\u77e5\u6a5f\u80fd\u969c\u5bb3 (MCI)\u60a3\u8005\u3092\u5bfe\u8c61\u3068\u3057\u305f\u7cbe\u795e\u79d1\u30c7\u30a4\u30b1\u30a2\u306e\u53d6\u308a\u7d44\u307f. \u7b2c29\u56de\u65e5\u672c\u8001\u5e74\u7cbe\u795e\u533b\u5b66\u4f1a, \u6771\u4eac, 2014\u5e746\u670812\u65e5<\/li>\n
        23. \u5c0f\u6797\u7985, \u6cb3\u4e0a\u7dd2, \u65b0\u4e95\u54f2\u660e, \u6a2a\u7530\u4fee, \u5927\u5cf6\u5065\u4e00, \u65b0\u91cc\u548c\u5f18, \u79cb\u5c71\u6cbb\u5f66, \u6c34\u6fa4\u82f1\u6d0b\uff1b\u672c\u90a6\u306b\u304a\u3051\u308bbehavioral variant of frontotemporal dementia (bvFTD)\u306e\u81e8\u5e8a\u75c5\u7406\u50cf. \u7b2c55\u56de\u65e5\u672c\u795e\u7d4c\u5b66\u4f1a\u7dcf\u4f1a\u5b66\u8853\u7814\u7a76\u4f1a, \u6771\u4eac, 2014\u5e74\uff16\u6708\uff16\u65e5<\/li>\n
        24. \u7d30\u5ddd\u96c5\u4eba, \u65b0\u4e95\u54f2\u660e, \u9234\u639b\u96c5\u7f8e, \u8fd1\u85e4\u3072\u308d\u307f, \u677e\u8107\u8cb4\u5fd7, \u897f\u539f\u771f\u6749, \u9577\u8c37\u5ddd\u6210\u4eba, \u79cb\u5c71\u6cbb\u5f66: \u30bf\u30a6\u30c8\u30e9\u30f3\u30b9\u30b8\u30a7\u30cb\u30c3\u30af\u30de\u30a6\u30b9\u306b\u304a\u3044\u3066\u30d7\u30ed\u30b0\u30e9\u30cb\u30e5\u30ea\u30f3\u306e\u6e1b\u5c11\u306f\u30bf\u30a6\u306e\u30ea\u30f3\u9178\u5316\u306b\u5f71\u97ff\u3092\u4e0e\u3048\u308b. \u7b2c61\u56de\u65e5\u672c\u5b9f\u9a13\u52d5\u7269\u5b66\u4f1a, \u672d\u5e4c, 2014\u5e745\u670815\u65e5<\/li>\n<\/ol>\n

           <\/p>\n

          \u8b1b\u6f14\u4f1a\u305d\u306e\u4ed6<\/p>\n

            \n
          1. \u65b0\u4e95\u54f2\u660e: \u8a8d\u77e5\u75c7\u3000\u57fa\u672c\u7684\u306a\u533b\u5b66\u77e5\u8b58\u3068\u6700\u65b0\u60c5\u5831. 2014\u5e74\u5ea6\u30bd\u30fc\u30b7\u30e3\u30eb\u30ef\u30fc\u30af\u30b9\u30ad\u30eb\u30a2\u30c3\u30d7\u7814\u4fee \u8a8d\u77e5\u75c7\u9ad8\u9f62\u8005\u3078\u306e\u30bd\u30fc\u30b7\u30e3\u30eb\u30ef\u30fc\u30af\u652f\u63f4, \u6771\u4eac,\u00a0 2015\u5e743\u670829\u65e5<\/li>\n
          2. \u65b0\u4e95\u54f2\u660e: \u8a8d\u77e5\u75c7\u306eBPSD\u306e\u75c5\u614b\u3068\u6cbb\u7642. \u7b2c2\u56de\u6a5f\u80fd\u7684\u81e8\u5e8a\u795e\u7d4c\u5b66\u30b5\u30ed\u30f3, \u3064\u304f\u3070, 2015\u5e743\u670811\u65e5<\/li>\n
          3. \u65b0\u4e95\u54f2\u660e: \u8133\u306e\u75c5\u7406\u5909\u5316\u304b\u3089\u307f\u308b\u8a8d\u77e5\u75c7\u306e\u8a3a\u65ad\u3068\u4e88\u9632. \u7b2c\uff18\u56de\u8a8d\u77e5\u75c7\u75be\u60a3\u533b\u7642\u30bb\u30f3\u30bf\u30fc\u7814\u4fee\u4f1a, \u65e5\u7acb, 2015\u5e742\u670827\u65e5<\/li>\n
          4. \u65b0\u4e95\u54f2\u660e: \u82e5\u5e74\u6027\u8a8d\u77e5\u75c7\u306e\u8a3a\u65ad\u3068\u6cbb\u7642. \u533b\u7642\u6cd5\u4eba\u793e\u56e3\u6709\u670b\u4f1a\u6817\u7530\u75c5\u9662\u3000\u5e73\u621026\u5e74\u5ea6\u8a8d\u77e5\u75c7\u75be\u60a3\u30bb\u30f3\u30bf\u30fc\u7814\u4fee\u4f1a, \u3072\u305f\u3061\u306a\u304b, 2015\u5e742\u670820\u65e5<\/li>\n
          5. \u65b0\u4e95\u54f2\u660e: \u8a8d\u77e5\u75c7\u306e\u6700\u65b0\u533b\u7642\u3068\u5c55\u671b. \u8a8d\u77e5\u75c7\u3092\u7406\u89e3\u3059\u308b\u7814\u4fee\u4f1a, \u3064\u304f\u3070, 2014\u5e7412\u670822\u65e5<\/li>\n
          6. \u65b0\u4e95\u54f2\u660e: \u4ecb\u8b77\u8005\u304b\u3089\u307f\u305f\u8a8d\u77e5\u75c7\u306e\u898b\u5206\u3051\u65b9. \u6c34\u6238, 2014\u5e7412\u670814\u65e5<\/li>\n
          7. \u65b0\u4e95\u54f2\u660e: \u8a8d\u77e5\u75c7\u306e\u6cbb\u7642\u3068\u4e88\u9632. \u9e7f\u884c\u5730\u533a\u8a8d\u77e5\u75c7\u6cbb\u7642\u3092\u8003\u3048\u308b\u4f1a, \u795e\u6816, 2014\u5e7412\u67084\u65e5<\/li>\n
          8. \u592a\u5200\u5ddd \u5f18\u548c;\u00a0\u81ea\u6bba\u306e\u30b2\u30fc\u30c8\u30ad\u30fc\u30d1\u30fc\u7814\u4fee\u3000\u533b\u7642\u8005\u304c\u8eab\u306b\u7740\u3051\u308b\u3079\u304d\u81ea\u6bba\u4e88\u9632\u306e\u5b9f\u8df5\uff08\u57fa\u790e\u7de8\uff09.\u5e73\u621026\u5e74\u5ea6\u7b51\u6ce2\u5927\u5b66\u9644\u5c5e\u75c5\u9662\u770b\u8b77\u90e8\u7ba1\u7406\u8005\u7814\u4fee, 2014\u5e7412\u67084\u65e5<\/li>\n
          9. \u592a\u5200\u5ddd \u5f18\u548c;\u00a0<\/em>\u82e5\u8005\u306e\u3053\u3053\u308d\u306e\u75c5\uff1a\u3069\u3053\u304b\u3089\u9752\u6625\u3001\u3069\u3053\u304b\u3089\u75c5\u6c17\uff1f\u5e73\u621019\uff5e24\u5e74\u5ea6\u30aa\u30fc\u30d7\u30f3\u6559\u80b2\u30bb\u30f3\u30bf\u30fc\u8a2d\u7f6e\u79d1\u76ee\u30e1\u30f3\u30bf\u30eb\u30d8\u30eb\u30b9\u30de\u30cd\u30b8\u30e1\u30f3\u30c8\u6982\u8ad6, 2014\u5e7412\u67083\u65e5<\/li>\n
          10. \u65b0\u4e95\u54f2\u660e: \u8a8d\u77e5\u75c7\u6027\u795e\u7d4c\u5909\u6027\u75be\u60a3\u306b\u304a\u3051\u308b\u30bf\u30a6\u306e\u91cd\u8981\u6027. \u7b2c33\u56de\u65e5\u672c\u8a8d\u77e5\u75c7\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a, \u6a2a\u6d5c, 2014\u5e7411\u670830\u65e5<\/li>\n
          11. \u677e\ufa11 \u671d\u6a39;\u00a0\u7d71\u5408\u5931\u8abf\u75c7\u306b\u4f34\u3046\u30ea\u30b9\u30af\u3068\u306f\u3002\u305d\u3057\u3066\u3001\u30bc\u30d7\u30ea\u30aa\u30f3\u306b\u4f34\u3046\u30ea\u30b9\u30af\u3068\u306f,\u00a0ATLAS-Second-Expert Meeting, 2014\u5e7411\u67088\u65e5<\/li>\n
          12. \u677e\ufa11 \u671d\u6a39;\u65e5\u5e38\u81e8\u5e8a\u306e\u4e2d\u306eDSM-5,\u00a0\u8328\u57ce\u770c\u7cbe\u795e\u79d1\u8a3a\u65ad\u8b1b\u6f14\u4f1a, 2014\u5e7410\u670830\u65e5<\/li>\n
          13. \u65b0\u4e95\u54f2\u660e: \u75c5\u7406\u304b\u3089\u307f\u305f\u30ec\u30d3\u30fc\u5c0f\u4f53\u75c5\u306e\u75c7\u72b6\u767a\u751f\u6a5f\u5e8f. \u57fa\u790e\u30fb\u81e8\u5e8a\u7d71\u5408\u30ab\u30f3\u30d5\u30a1\u30ec\u30f3\u30b91, \u7b2c36\u65e5\u672c\u751f\u7269\u5b66\u7684\u7cbe\u795e\u533b\u5b66\u4f1a, \u5948\u826f, 2014\u5e749\u670829\u65e5<\/li>\n
          14. \u677e\ufa11 \u671d\u6a39;DSM-5\u3092\u65ac\u308b\u3000\uff5e\u6210\u4eba\u306eADHD\u3001\u8001\u5e74\u671f\u3046\u3064\u75c5\u3001\u5973\u6027\u306e\u6c17\u5206\u969c\u5bb3\uff5e,\u00a0\u7b2c4\u56de\u7cbe\u795e\u79d1\u5b9f\u81e8\u5e8a\u304b\u3089DSM-5\u3092\u8003\u3048\u308b\u4f1a, 2014\u5e749\u670826\u65e5<\/li>\n
          15. \u592a\u5200\u5ddd \u5f18\u548c;\u00a0DVD\u300e\u3042\u306a\u305f\u304c\u30b2\u30fc\u30c8\u30ad\u30fc\u30d1\u30fc\u306b\u306a\u308b\u6642\u300f\u3092\u7528\u3044\u305f\u7814\u4fee\u4f1a\u306e\u9032\u3081\u65b9, \u5e73\u621026\u5e74\u5ea6\u8328\u57ce\u770c\u30b2\u30fc\u30c8\u30ad\u30fc\u30d1\u30fc\u6307\u5c0e\u8005\u7814\u4fee\u4f1a, 2012\u5e747\u670811\u65e5<\/li>\n
          16. \u65b0\u4e95\u54f2\u660e: \u524d\u982d\u5074\u982d\u578b\u8a8d\u77e5\u75c7\u306e\u81e8\u5e8a\u75c5\u7406\u306e\u65b0\u77e5\u8b58. \u30ef\u30fc\u30af\u30b7\u30e7\u30c3\u30d71 \u7cbe\u795e\u79d1\u533b\u304c\u77e5\u3063\u3066\u304a\u304f\u3079\u304d\u795e\u7d4c\u5b66\u306e\u65b0\u77e5\u8b58, \u7b2c110\u56de\u65e5\u672c\u7cbe\u795e\u795e\u7d4c\u5b66\u4f1a\u5b66\u8853\u7dcf\u4f1a, \u6a2a\u6d5c,2014\u5e746\u670826\u65e5<\/li>\n
          17. \u65b0\u4e95\u54f2\u660e: \u524d\u982d\u5074\u982d\u8449\u5909\u6027\u75c7(FTLD)\u306e\u75c7\u5019\u3068\u75c5\u7406. \u8a8d\u77e5\u75c7\u30d5\u30a1\u30a4\u30e4\u30fc\u30ab\u30f3\u30d5\u30a1\u30ec\u30f3\u30b9. \u540d\u53e4\u5c4b,2014\u5e746\u670821\u65e5<\/li>\n
          18. \u677e\ufa11 \u671d\u6a39;DSM-5\u3092\u65ac\u308b\u3000\uff5e\u5150\u7ae5\u601d\u6625\u671f\u3001\u3046\u3064\u75c5\u3001\u30ab\u30bf\u30c8\u30cb\u30a2\uff5e,\u00a0\u7b2c3\u56de\u7cbe\u795e\u79d1\u5b9f\u81e8\u5e8a\u304b\u3089DSM-5\u3092\u8003\u3048\u308b\u4f1a, 2014\u5e745\u670830\u65e5<\/li>\n
          19. \u65b0\u4e95\u54f2\u660e: \u5206\u5b50\u751f\u5316\u5b66\u304b\u3089\u307f\u305fPSP\u3068CBD. Super Expert Session 3, PSP\u3068CBD:\u9451\u5225\u306f\u53ef\u80fd\u304b, \u7b2c55\u56de\u65e5\u672c\u795e\u7d4c\u5b66\u4f1a\u5b66\u8853\u5927\u4f1a, \u798f\u5ca1,2014\u5e745\u670824\u65e5<\/li>\n
          20. \u677e\ufa11 \u671d\u6a39;DSM-5\u306b\u3064\u3044\u3066\u3000\uff5e\u7d71\u5408\u5931\u8abf\u75c7\u3092\u4e2d\u5fc3\u306b\uff5e,\u00a0\u5e73\u621026\u5e74\u5ea6\u7b2c\uff11\u56de\u7cbe\u795e\u79d1\u5c02\u9580\u9818\u57df\u85ac\u5264\u5e2b\u990a\u6210\u7814\u4fee\u4f1a, 2014\u5e745\u670810\u65e5<\/li>\n
          21. \u65b0\u4e95\u54f2\u660e: \u305b\u3093\u5984\u306e\u8a3a\u65ad\u3068\u6cbb\u7642. \u5b88\u8c37\u6176\u53cb\u75c5\u9662\u8b1b\u6f14\u4f1a, \u5b88\u8c37,2014\u5e744\u670818\u65e5<\/li>\n<\/ol>\n

             <\/p>\n

             <\/p>\n","protected":false},"excerpt":{"rendered":"

            \u79c1\u305f\u3061\u7cbe\u795e\u533b\u5b66\u30b0\u30eb\u30fc\u30d7\u306e2014\u5e74\u306e\u696d\u7e3e\u3092\u7d39\u4ecb\u3057\u307e\u3059\u3002 \u539f\u8457 Yoshita M … <\/p>\n","protected":false},"author":5,"featured_media":0,"parent":253,"menu_order":10,"comment_status":"closed","ping_status":"closed","template":"","meta":{"footnotes":""},"_links":{"self":[{"href":"https:\/\/www.tsukuba-psychiatry.com\/index.php?rest_route=\/wp\/v2\/pages\/1321"}],"collection":[{"href":"https:\/\/www.tsukuba-psychiatry.com\/index.php?rest_route=\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.tsukuba-psychiatry.com\/index.php?rest_route=\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.tsukuba-psychiatry.com\/index.php?rest_route=\/wp\/v2\/users\/5"}],"replies":[{"embeddable":true,"href":"https:\/\/www.tsukuba-psychiatry.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=1321"}],"version-history":[{"count":13,"href":"https:\/\/www.tsukuba-psychiatry.com\/index.php?rest_route=\/wp\/v2\/pages\/1321\/revisions"}],"predecessor-version":[{"id":4256,"href":"https:\/\/www.tsukuba-psychiatry.com\/index.php?rest_route=\/wp\/v2\/pages\/1321\/revisions\/4256"}],"up":[{"embeddable":true,"href":"https:\/\/www.tsukuba-psychiatry.com\/index.php?rest_route=\/wp\/v2\/pages\/253"}],"wp:attachment":[{"href":"https:\/\/www.tsukuba-psychiatry.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=1321"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}